comparemela.com

Latest Breaking News On - Hedge funds weigh in on novabay pharmaceuticals - Page 1 : comparemela.com

StockNews com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

Analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % NYSE:NBY opened at $0.13 on Friday. The business’s 50-day simple moving average is $0.10 […]

NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. NovaBay Pharmaceuticals Trading Down 1.2 % Shares of NBY stock opened at $0.12 on Friday. The stock has a market capitalization of $4.49 million, a P/E ratio of […]

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews com

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a report issued on Monday. The brokerage set a “sell” rating on the stock. NovaBay Pharmaceuticals Stock Performance NBY opened at $0.17 on Monday. NovaBay Pharmaceuticals has a 12 month low of $0.12 and a 12 month high of $2.60. The […]

NovaBay Pharmaceuticals, Inc (NYSEAMERICAN:NBY) Short Interest Down 39 1% in November

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 56,400 shares, a decrease of 39.1% from the October 31st total of 92,600 shares. Based on an average daily volume of 1,100,000 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.